Innate Pharma to participate in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences:  

•    Citi’s 17th Annual BioPharma Conference
Event Date: September 7-8, 2022 (in-person event)

•    H.C. Wainwright 24th Annual Global Investment Conference
Event Date: September 12-14, 2022